RAMM Pharma Corp.
RAMM
CNSX
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -725.70K | -1.28M | -1.70M | -2.84M | -778.70K |
| Total Depreciation and Amortization | 223.20K | 228.60K | 230.30K | 165.80K | 261.00K |
| Total Amortization of Deferred Charges | 300.00 | -- | -- | -- | -- |
| Total Other Non-Cash Items | -115.40K | 75.70K | 589.40K | 1.70M | -168.40K |
| Change in Net Operating Assets | -225.90K | 208.00K | -9.00K | -36.70K | 194.00K |
| Cash from Operations | -843.50K | -765.50K | -886.70K | -1.01M | -492.20K |
| Capital Expenditure | -9.10K | -100.00 | -9.60K | -38.60K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 103.00K | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.60K | -30.90K | 41.80K | 21.80K | 23.20K |
| Cash from Investing | -14.70K | -30.90K | 32.20K | 86.20K | 23.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -58.10K | -57.90K | -56.30K | -42.90K | -46.90K |
| Issuance of Common Stock | -- | -- | -- | 1.50K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -120.70K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.40K | -16.20K | -- | 33.10K | -12.30K |
| Cash from Financing | -48.60K | -54.60K | -41.70K | -6.10K | -134.80K |
| Foreign Exchange rate Adjustments | 2.40K | 6.30K | -10.00K | 21.50K | -7.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -904.50K | -844.80K | -906.20K | -910.60K | -611.30K |
